CGRP Inhibition, Autonomic Function, and Migraine

NCT04628429 · clinicaltrials.gov ↗

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Episodic Migraine
Chronic Migraine

Interventions

DRUG: Erenumab
DRUG: Galcanezumab
DRUG: Fremanezumab

Sponsor

Medical University of Vienna